Skip to main content
William Weintraub, MD, Cardiology, Newark, DE, ChristianaCare

WilliamSWeintraubMD

Cardiology Newark, DE

Adult Congenital Heart Disease, Interventional Cardiology

Physician

Dr. Weintraub is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Weintraub's full profile

Already have an account?

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 1978 - 1979
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1977 - 1978
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1975 - 1977
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1975

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2017 - 2024
  • PA State Medical License
    PA State Medical License 1979 - 2024
  • DE State Medical License
    DE State Medical License 2005 - 2019
  • GA State Medical License
    GA State Medical License 1986 - 2011
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Evaluating Clinical Outcomes from Administrative Databases  
    William Weintraub, MD, JACC: Cardiovascular Imaging
  • Surgical Aortic Valve Replacement in the Transcatheter Aortic Valve Replacement Era  
    William S Weintraub, Lowell F Satler, Vinod H Thourani, ScienceDirect
  • A Narrative Overview: Have Clinical Trials of PCI vs Medical Therapy Addressed the Right Question?  
    William Weintraub, MD, International Journal of Cardiology

Lectures

  • Do We Have the COURAGE to Revascularize for Stable Angina in a Post-ORBITA Era? Should We Worry About ISCHEMIA? 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Authored Content

  • Evaluating Clinical Outcomes from Administrative DatabasesJuly 2020

Press Mentions

  • PPI Use in Type 2 Diabetes Links with Cardiovascular Events
    PPI Use in Type 2 Diabetes Links with Cardiovascular EventsJanuary 11th, 2023
  • JAMA Publication Highlights VASCEPA® (Icosapent Ethyl) Cardiovascular Risk Reduction Extends to Cost Effectiveness at Patient Level
    JAMA Publication Highlights VASCEPA® (Icosapent Ethyl) Cardiovascular Risk Reduction Extends to Cost Effectiveness at Patient LevelMarch 1st, 2022
  • Icosapent Ethyl Cost-Effective Compared with Standard Care: REDUCE-IT
    Icosapent Ethyl Cost-Effective Compared with Standard Care: REDUCE-ITFebruary 17th, 2022
  • Join now to see all

Grant Support

  • Accf-Sts Database Collaboration On The Comparative Effectiveness Of PCI And CABGNational Heart, Lung, And Blood Institute2009–2010
  • Serum Marker Of Oxidative Stress &Vascular InflammationNational Center For Research Resources2004
  • Exercise And Cardiovascular DiseaseNational Heart, Lung, And Blood Institute2003

Professional Memberships

Hospital Affiliations